{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:46:41Z","timestamp":1761540401798,"version":"3.44.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0002-9343(02)01277-9","type":"journal-article","created":{"date-parts":[[2002,11,12]],"date-time":"2002-11-12T12:32:32Z","timestamp":1037104352000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S","title":["Effects of glycemic control and other determinants on vascular disease in type 2 diabetes"],"prefix":"10.1016","volume":"113","author":[{"given":"Burton E","family":"Sobel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(02)01277-9_BIB1","unstructured":"American Diabetes Association. Diabetes facts and figures: the dangerous toll of diabetes. Available at: www.diabetes.org\/ada\/facts.asp. Accessed June 12, 2001."},{"key":"10.1016\/S0002-9343(02)01277-9_BIB2","series-title":"Diabetes in America","first-page":"233","article-title":"Mortality in non-insulin-dependent diabetes","author":"Geiss","year":"1995"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmr.5610030206","article-title":"Diabetes and atherosclerosis","volume":"3","author":"Py\u00f6r\u00e4l\u00e4","year":"1997","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diab.43.8.960","article-title":"NIDDM and its metabolic control predict coronary heart disease in elderly subjects","volume":"43","author":"Kuusisto","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35)","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB9","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.314.7093.1512","article-title":"Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus","volume":"314","author":"Malmberg","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.ATV.12.6.647","article-title":"Atherogenesis in diabetes","volume":"12","author":"Bierman","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diab.47.2.290","article-title":"Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects","volume":"47","author":"Calles-Escandon","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diab.34.9.836","article-title":"Fibrinopeptide-A in diabetes mellitus","volume":"34","author":"Jones","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB14","first-page":"187","article-title":"Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis","volume":"22","author":"Keber","year":"1992","journal-title":"Haemostasis"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0038-1649631","article-title":"Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients","volume":"70","author":"Lupu","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB16","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.CIR.94.9.2171","article-title":"Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM","volume":"94","author":"Mansfield","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diab.43.1.104","article-title":"Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients","volume":"43","author":"McGill","year":"1994","journal-title":"Diabetes"},{"issue":"suppl","key":"10.1016\/S0002-9343(02)01277-9_BIB18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2310\/6650.2001.34106","article-title":"Events at the vascular wall","volume":"49","author":"Prescott","year":"2001","journal-title":"J Invest Med"},{"issue":"suppl","key":"10.1016\/S0002-9343(02)01277-9_BIB19","first-page":"13","article-title":"Syndrome X","volume":"736","author":"Reaven","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0038-1657622","article-title":"Thrombolytic therapy","volume":"78","author":"Collen","year":"1997","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/S0002-9343(02)01277-9_BIB21","first-page":"78","article-title":"Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity","volume":"32","author":"Juhan-Vague","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0038-1657607","article-title":"PAI-1, obesity, insulin resistance and risk of cardiovascular events","volume":"78","author":"Juhan-Vague","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s001250100618","article-title":"Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor type-1 by proinsulin","volume":"44","author":"Nordt","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB24","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1161\/01.ATV.17.11.3294","article-title":"Changes in arterial expression of fibrinolytic system proteins in atherogenesis","volume":"17","author":"Schneider","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB25","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.88.22.9959","article-title":"Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I","volume":"88","author":"Schneider","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB26","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1006\/jmcc.1998.0719","article-title":"Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo","volume":"30","author":"Nordt","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.CIR.91.3.764","article-title":"Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo","volume":"91","author":"Nordt","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.89.1.321","article-title":"Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin","volume":"89","author":"Nordt","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB29","doi-asserted-by":"crossref","unstructured":"Nordt TK, Lutzi S, Ruef J, et al. Attenuation by fibrates of expression of plasminogen activator inhibitor type-1 expression in cultured human arterial smooth muscle cells. Thromb Haemost. 2001;86:1305\u20131313","DOI":"10.1055\/s-0037-1616066"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB30","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1016\/S0021-9258(18)42289-2","article-title":"Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1","volume":"267","author":"Fattal","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB32","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.96.6.1761","article-title":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB33","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.93.9.1613","article-title":"Potentiation of vasculopathy by insulin","volume":"93","author":"Sobel","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB34","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.97.22.2213","article-title":"Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients","volume":"97","author":"Sobel","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/hq0801.093667","article-title":"Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects","volume":"21","author":"Pandolfi","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.RES.67.1.61","article-title":"Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery","volume":"67","author":"Clowes","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB37","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0167-5273(97)02957-4","article-title":"Changing paradigms in thrombolysis in acute myocardial infarction","volume":"59","author":"Gotsman","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB39","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1161\/01.CIR.96.9.3180","article-title":"Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation","volume":"96","author":"Carmeliet","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB40","doi-asserted-by":"crossref","first-page":"114E","DOI":"10.1016\/0002-9149(89)90242-7","article-title":"Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes","volume":"63","author":"Falk","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/hrt.60.6.459","article-title":"Morphology of the endothelium over atherosclerotic plaques in human coronary arteries","volume":"60","author":"Davies","year":"1988","journal-title":"Br Heart J"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB42","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","article-title":"Stability and instability","volume":"94","author":"Davies","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB43","unstructured":"Sobel BE. Cardiovascular disease in type 2 diabetes: implications of elevated PAI-1 in blood and tissues [National Diabetes Education Initiative Web site]. Available at: http:\/\/www.ndei.org\/content\/symposia\/symposia_highlights\/111300\/abstract02.asp. Accessed July 25, 2001\/"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB44","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diabetes.49.4.633","article-title":"Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects","volume":"49","author":"Kruszynska","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diacare.16.4.621","article-title":"Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects","volume":"16","author":"Nagi","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB47","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB48","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome","volume":"46","author":"Velazquez","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB49","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1210\/jcem.83.5.4932","article-title":"Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes","volume":"83","author":"Minamikawa","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.CIR.43.1.67","article-title":"Factors influencing infarct size following experimental coronary artery occlusions","volume":"43","author":"Maroko","year":"1971","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB51","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJM200004063421408","article-title":"Coronary heart disease in patients with diabetes","volume":"342","author":"Haffner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB52","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.CIR.103.9.1185","article-title":"Acceleration of restenosis by diabetes","volume":"103","author":"Sobel","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB53","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1161\/01.ATV.20.12.2696","article-title":"Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene","volume":"20","author":"Chen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB54","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/01.ATV.20.10.2297","article-title":"Role of the angiotensin AT1 receptor in rat aortic and cardiac PAI-1 gene expression","volume":"20","author":"Chen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB55","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI117786","article-title":"Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells","volume":"95","author":"Feener","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB56","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.CIR.93.6.1073","article-title":"Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta","volume":"93","author":"Hamdan","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01060734","article-title":"Potential antithrombotic and fibrinolytic properties of the angiotensin converting enzyme inhibitors","volume":"1","author":"Ridker","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB58","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1161\/01.CIR.103.25.3123","article-title":"Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice","volume":"103","author":"Zaman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.CIR.104.2.181","article-title":"Platelet reactivity characterized prospectively","volume":"104","author":"Kabbani","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB60","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.CIR.103.9.1218","article-title":"Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up","volume":"103","author":"Van Belle","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB61","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0735-1097(99)00650-6","article-title":"Abciximab reduces mortality in diabetics following percutaneous coronary intervention","volume":"35","author":"Bhatt","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB62","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.102.20.2466","article-title":"Glycoprotein IIb\/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina\/non-ST-elevation myocardial infarction","volume":"102","author":"Th\u00e9roux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0735-1097(89)90053-3","article-title":"The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction","volume":"14","author":"Stone","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB64","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.CIR.102.9.1014","article-title":"Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction","volume":"102","author":"Malmberg","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(97)00047-3","article-title":"Regulation of energy substrate metabolism in the diabetic heart","volume":"34","author":"Stanley","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1006882805197","article-title":"Metabolic disturbances in diabetic cardiomyopathy","volume":"180","author":"Rodrigues","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00132580-200107000-00009","article-title":"Ranolazine","volume":"3","author":"Anderson","year":"2001","journal-title":"Heart Dis"},{"key":"10.1016\/S0002-9343(02)01277-9_BIB68","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diab.43.6.836","article-title":"Glycation and diabetic complications","volume":"43","author":"Brownlee","year":"1994","journal-title":"Diabetes"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302012779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302012779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:22:42Z","timestamp":1757578962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934302012779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0002934302012779"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(02)01277-9","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of glycemic control and other determinants on vascular disease in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(02)01277-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}